Guardian Pharmacy Services, Inc. (NYSE: GRDN) Stock Competitors & Peer Comparison
See GRDN's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for GRDN and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| GRDN | $38.43 | -0.08% | 2.4B | 33.72 | $1.14 | N/A |
| HCA | $404.68 | -1.71% | 87.6B | 13.97 | $28.96 | +0.74% |
| THC | $267.90 | +0.32% | 21.6B | 15.54 | $17.24 | N/A |
| FMS | $23.77 | +0.59% | 12.8B | 8.93 | $2.66 | +3.64% |
| EHC | $123.59 | +0.03% | 12.3B | 21.16 | $5.84 | +0.61% |
| BTSGU | $203.17 | +1.04% | 12B | 184.06 | $1.11 | N/A |
| DVA | $180.06 | -0.79% | 11.5B | 14.00 | $12.80 | N/A |
| ENSG | $181.65 | -0.13% | 10.6B | 26.33 | $6.90 | +0.14% |
| UHS | $170.02 | -0.70% | 10.3B | 7.54 | $22.54 | +0.47% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
GRDN vs HCA Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, HCA has a market cap of 87.6B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while HCA trades at $404.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas HCA's P/E ratio is 13.97. In terms of profitability, GRDN's ROE is +0.31%, compared to HCA's ROE of -1.13%. Regarding short-term risk, GRDN is more volatile compared to HCA. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
GRDN vs THC Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, THC has a market cap of 21.6B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while THC trades at $267.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas THC's P/E ratio is 15.54. In terms of profitability, GRDN's ROE is +0.31%, compared to THC's ROE of +0.51%. Regarding short-term risk, GRDN is more volatile compared to THC. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check THC's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
GRDN vs FMS Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, FMS has a market cap of 12.8B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while FMS trades at $23.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas FMS's P/E ratio is 8.93. In terms of profitability, GRDN's ROE is +0.31%, compared to FMS's ROE of +0.07%. Regarding short-term risk, GRDN is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check FMS's competition here
Encompass Health Corporation (NYSE: EHC)
GRDN vs EHC Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, EHC has a market cap of 12.3B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while EHC trades at $123.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas EHC's P/E ratio is 21.16. In terms of profitability, GRDN's ROE is +0.31%, compared to EHC's ROE of +0.25%. Regarding short-term risk, GRDN is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check EHC's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
GRDN vs BTSGU Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, BTSGU has a market cap of 12B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while BTSGU trades at $203.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas BTSGU's P/E ratio is 184.06. In terms of profitability, GRDN's ROE is +0.31%, compared to BTSGU's ROE of +0.15%. Regarding short-term risk, GRDN is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check BTSGU's competition here
DaVita Inc. (NYSE: DVA)
GRDN vs DVA Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, DVA has a market cap of 11.5B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while DVA trades at $180.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas DVA's P/E ratio is 14.00. In terms of profitability, GRDN's ROE is +0.31%, compared to DVA's ROE of -1.24%. Regarding short-term risk, GRDN is more volatile compared to DVA. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check DVA's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
GRDN vs ENSG Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, ENSG has a market cap of 10.6B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while ENSG trades at $181.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas ENSG's P/E ratio is 26.33. In terms of profitability, GRDN's ROE is +0.31%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, GRDN is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check ENSG's competition here
Universal Health Services, Inc. (NYSE: UHS)
GRDN vs UHS Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, UHS has a market cap of 10.3B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while UHS trades at $170.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas UHS's P/E ratio is 7.54. In terms of profitability, GRDN's ROE is +0.31%, compared to UHS's ROE of +0.21%. Regarding short-term risk, GRDN is more volatile compared to UHS. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check UHS's competition here
Oak Street Health, Inc. (NYSE: OSH)
GRDN vs OSH Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas OSH's P/E ratio is -17.65. In terms of profitability, GRDN's ROE is +0.31%, compared to OSH's ROE of +4.64%. Regarding short-term risk, GRDN is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check OSH's competition here
PACS Group, Inc. (NYSE: PACS)
GRDN vs PACS Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, PACS has a market cap of 7B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while PACS trades at $44.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas PACS's P/E ratio is 23.51. In terms of profitability, GRDN's ROE is +0.31%, compared to PACS's ROE of +0.27%. Regarding short-term risk, GRDN is more volatile compared to PACS. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check PACS's competition here
Chemed Corporation (NYSE: CHE)
GRDN vs CHE Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, CHE has a market cap of 7B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while CHE trades at $532.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas CHE's P/E ratio is 24.67. In terms of profitability, GRDN's ROE is +0.31%, compared to CHE's ROE of +0.29%. Regarding short-term risk, GRDN is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check CHE's competition here
LHC Group, Inc. (NASDAQ: LHCG)
GRDN vs LHCG Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas LHCG's P/E ratio is 82.83. In terms of profitability, GRDN's ROE is +0.31%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, GRDN is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
GRDN vs LFST Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, LFST has a market cap of 4.8B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while LFST trades at $12.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas LFST's P/E ratio is 93.55. In terms of profitability, GRDN's ROE is +0.31%, compared to LFST's ROE of +0.03%. Regarding short-term risk, GRDN is less volatile compared to LFST. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
GRDN vs CON Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, CON has a market cap of 4.5B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while CON trades at $35.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas CON's P/E ratio is 24.59. In terms of profitability, GRDN's ROE is +0.31%, compared to CON's ROE of +0.47%. Regarding short-term risk, GRDN is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check CON's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
GRDN vs OPCH Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, OPCH has a market cap of 3.6B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while OPCH trades at $23.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas OPCH's P/E ratio is 13.92. In terms of profitability, GRDN's ROE is +0.31%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, GRDN is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check OPCH's competition here
National HealthCare Corporation (AMEX: NHC)
GRDN vs NHC Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, NHC has a market cap of 3.5B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while NHC trades at $223.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas NHC's P/E ratio is 28.34. In terms of profitability, GRDN's ROE is +0.31%, compared to NHC's ROE of +0.13%. Regarding short-term risk, GRDN is less volatile compared to NHC. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check NHC's competition here
Amedisys, Inc. (NASDAQ: AMED)
GRDN vs AMED Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas AMED's P/E ratio is 39.30. In terms of profitability, GRDN's ROE is +0.31%, compared to AMED's ROE of +0.11%. Regarding short-term risk, GRDN is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check AMED's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
GRDN vs BKD Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, BKD has a market cap of 3B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while BKD trades at $12.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas BKD's P/E ratio is -21.77. In terms of profitability, GRDN's ROE is +0.31%, compared to BKD's ROE of +4.06%. Regarding short-term risk, GRDN is more volatile compared to BKD. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check BKD's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
GRDN vs ACHC Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, ACHC has a market cap of 2.9B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while ACHC trades at $30.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas ACHC's P/E ratio is 15.49. In terms of profitability, GRDN's ROE is +0.31%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, GRDN is less volatile compared to ACHC. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check ACHC's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
GRDN vs AVAH Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, AVAH has a market cap of 2.7B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while AVAH trades at $12.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas AVAH's P/E ratio is 18.12. In terms of profitability, GRDN's ROE is +0.31%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, GRDN is less volatile compared to AVAH. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check AVAH's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
GRDN vs MD Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while MD trades at $26.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas MD's P/E ratio is 11.88. In terms of profitability, GRDN's ROE is +0.31%, compared to MD's ROE of +0.20%. Regarding short-term risk, GRDN is more volatile compared to MD. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check MD's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
GRDN vs ADUS Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while ADUS trades at $116.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas ADUS's P/E ratio is 17.37. In terms of profitability, GRDN's ROE is +0.31%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, GRDN is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check ADUS's competition here
Select Medical Holdings Corporation (NYSE: SEM)
GRDN vs SEM Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, SEM has a market cap of 2B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas SEM's P/E ratio is 15.43. In terms of profitability, GRDN's ROE is +0.31%, compared to SEM's ROE of +0.08%. Regarding short-term risk, GRDN is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check SEM's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
GRDN vs ASTH Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, ASTH has a market cap of 2B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while ASTH trades at $40.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas ASTH's P/E ratio is 39.24. In terms of profitability, GRDN's ROE is +0.31%, compared to ASTH's ROE of +0.05%. Regarding short-term risk, GRDN is less volatile compared to ASTH. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check ASTH's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
GRDN vs SGRY Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, SGRY has a market cap of 2B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while SGRY trades at $15.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas SGRY's P/E ratio is 38.54. In terms of profitability, GRDN's ROE is +0.31%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, GRDN is more volatile compared to SGRY. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check SGRY's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
GRDN vs SNDA Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, SNDA has a market cap of 1.9B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while SNDA trades at $39.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas SNDA's P/E ratio is -7.25. In terms of profitability, GRDN's ROE is +0.31%, compared to SNDA's ROE of -0.26%. Regarding short-term risk, GRDN is more volatile compared to SNDA. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check SNDA's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
GRDN vs AMEH Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas AMEH's P/E ratio is 39.25. In terms of profitability, GRDN's ROE is +0.31%, compared to AMEH's ROE of +0.05%. Regarding short-term risk, GRDN is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check AMEH's competition here
Agilon Health, Inc. (NYSE: AGL)
GRDN vs AGL Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, AGL has a market cap of 1.6B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while AGL trades at $96.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas AGL's P/E ratio is -10.83. In terms of profitability, GRDN's ROE is +0.31%, compared to AGL's ROE of -1.19%. Regarding short-term risk, GRDN is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check AGL's competition here
Ardent Health Inc. (NYSE: ARDT)
GRDN vs ARDT Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, ARDT has a market cap of 1.6B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while ARDT trades at $10.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas ARDT's P/E ratio is 8.81. In terms of profitability, GRDN's ROE is +0.31%, compared to ARDT's ROE of +0.05%. Regarding short-term risk, GRDN is more volatile compared to ARDT. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check ARDT's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
GRDN vs HCSG Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, HCSG has a market cap of 1.5B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while HCSG trades at $21.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas HCSG's P/E ratio is 17.27. In terms of profitability, GRDN's ROE is +0.31%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, GRDN is more volatile compared to HCSG. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check HCSG's competition here
Innovage Holding Corp. (NASDAQ: INNV)
GRDN vs INNV Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, INNV has a market cap of 1.4B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while INNV trades at $10.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas INNV's P/E ratio is -117.89. In terms of profitability, GRDN's ROE is +0.31%, compared to INNV's ROE of -0.09%. Regarding short-term risk, GRDN is more volatile compared to INNV. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check INNV's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
GRDN vs PNTG Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, PNTG has a market cap of 1.4B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while PNTG trades at $39.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas PNTG's P/E ratio is 29.79. In terms of profitability, GRDN's ROE is +0.31%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, GRDN is more volatile compared to PNTG. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check PNTG's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
GRDN vs AMN Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while AMN trades at $34.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas AMN's P/E ratio is 11.44. In terms of profitability, GRDN's ROE is +0.31%, compared to AMN's ROE of +0.15%. Regarding short-term risk, GRDN is more volatile compared to AMN. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check AMN's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
GRDN vs NUTX Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, NUTX has a market cap of 1.3B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while NUTX trades at $187.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas NUTX's P/E ratio is 14.48. In terms of profitability, GRDN's ROE is +0.31%, compared to NUTX's ROE of +0.52%. Regarding short-term risk, GRDN is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check NUTX's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
GRDN vs USPH Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while USPH trades at $81.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas USPH's P/E ratio is 31.94. In terms of profitability, GRDN's ROE is +0.31%, compared to USPH's ROE of +0.00%. Regarding short-term risk, GRDN is less volatile compared to USPH. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check USPH's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
GRDN vs BKDT Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas BKDT's P/E ratio is N/A. In terms of profitability, GRDN's ROE is +0.31%, compared to BKDT's ROE of +4.06%. Regarding short-term risk, GRDN is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check BKDT's competition here
Talkspace, Inc. (NASDAQ: TALK)
GRDN vs TALK Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, TALK has a market cap of 879.4M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas TALK's P/E ratio is 774.34. In terms of profitability, GRDN's ROE is +0.31%, compared to TALK's ROE of +0.00%. Regarding short-term risk, GRDN is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check TALK's competition here
Fidelity Select Health Care Svcs Port (NASDAQ: FSHCX)
GRDN vs FSHCX Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, FSHCX has a market cap of 877.3M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while FSHCX trades at $116.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas FSHCX's P/E ratio is N/A. In terms of profitability, GRDN's ROE is +0.31%, compared to FSHCX's ROE of N/A. Regarding short-term risk, GRDN is more volatile compared to FSHCX. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check FSHCX's competition here
GMR Solutions Inc. (NYSE: GMRS)
GRDN vs GMRS Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, GMRS has a market cap of 718.9M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while GMRS trades at $13.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas GMRS's P/E ratio is 5.92. In terms of profitability, GRDN's ROE is +0.31%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, GRDN is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check GMRS's competition here
Enhabit, Inc. (NYSE: EHAB)
GRDN vs EHAB Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas EHAB's P/E ratio is -197.14. In terms of profitability, GRDN's ROE is +0.31%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, GRDN is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check EHAB's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
GRDN vs STLN Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, STLN has a market cap of 644.9M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while STLN trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas STLN's P/E ratio is N/A. In terms of profitability, GRDN's ROE is +0.31%, compared to STLN's ROE of +2.10%. Regarding short-term risk, GRDN is less volatile compared to STLN. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check STLN's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
GRDN vs TOI Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas TOI's P/E ratio is -14.25. In terms of profitability, GRDN's ROE is +0.31%, compared to TOI's ROE of +2.10%. Regarding short-term risk, GRDN is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check TOI's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
GRDN vs SRTA Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, SRTA has a market cap of 510.5M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while SRTA trades at $5.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas SRTA's P/E ratio is -27.81. In terms of profitability, GRDN's ROE is +0.31%, compared to SRTA's ROE of +0.14%. Regarding short-term risk, GRDN is more volatile compared to SRTA. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check SRTA's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
GRDN vs MCTA Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas MCTA's P/E ratio is 419.36. In terms of profitability, GRDN's ROE is +0.31%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, GRDN is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check MCTA's competition here
Community Health Systems, Inc. (NYSE: CYH)
GRDN vs CYH Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, CYH has a market cap of 419.5M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while CYH trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas CYH's P/E ratio is 4.08. In terms of profitability, GRDN's ROE is +0.31%, compared to CYH's ROE of +0.21%. Regarding short-term risk, GRDN is more volatile compared to CYH. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check CYH's competition here
Auna S.A. (NYSE: AUNA)
GRDN vs AUNA Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, AUNA has a market cap of 388.6M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while AUNA trades at $5.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas AUNA's P/E ratio is 4.73. In terms of profitability, GRDN's ROE is +0.31%, compared to AUNA's ROE of +0.04%. Regarding short-term risk, GRDN is more volatile compared to AUNA. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check AUNA's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
GRDN vs VMD Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, VMD has a market cap of 350.4M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while VMD trades at $9.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas VMD's P/E ratio is 25.56. In terms of profitability, GRDN's ROE is +0.31%, compared to VMD's ROE of +0.10%. Regarding short-term risk, GRDN is more volatile compared to VMD. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check VMD's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
GRDN vs AIRS Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, AIRS has a market cap of 242M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while AIRS trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas AIRS's P/E ratio is -114.33. In terms of profitability, GRDN's ROE is +0.31%, compared to AIRS's ROE of -0.13%. Regarding short-term risk, GRDN is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check AIRS's competition here
Capital Senior Living Corporation (NYSE: CSU)
GRDN vs CSU Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas CSU's P/E ratio is 0.67. In terms of profitability, GRDN's ROE is +0.31%, compared to CSU's ROE of -0.33%. Regarding short-term risk, GRDN is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check CSU's competition here
The Joint Corp. (NASDAQ: JYNT)
GRDN vs JYNT Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, JYNT has a market cap of 120.5M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while JYNT trades at $8.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas JYNT's P/E ratio is 84.50. In terms of profitability, GRDN's ROE is +0.31%, compared to JYNT's ROE of +0.22%. Regarding short-term risk, GRDN is more volatile compared to JYNT. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check JYNT's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
GRDN vs PARK Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, PARK has a market cap of 103.9M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while PARK trades at $22.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas PARK's P/E ratio is 31.11. In terms of profitability, GRDN's ROE is +0.31%, compared to PARK's ROE of -0.00%. Regarding short-term risk, GRDN is less volatile compared to PARK. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check PARK's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
GRDN vs FVE Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas FVE's P/E ratio is -5.64. In terms of profitability, GRDN's ROE is +0.31%, compared to FVE's ROE of -0.15%. Regarding short-term risk, GRDN is more volatile compared to FVE. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
GRDN vs KDLYW Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas KDLYW's P/E ratio is N/A. In terms of profitability, GRDN's ROE is +0.31%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, GRDN is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check KDLYW's competition here
biote Corp. (NASDAQ: BTMD)
GRDN vs BTMD Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, BTMD has a market cap of 64.8M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while BTMD trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas BTMD's P/E ratio is 13.36. In terms of profitability, GRDN's ROE is +0.31%, compared to BTMD's ROE of -0.09%. Regarding short-term risk, GRDN is more volatile compared to BTMD. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check BTMD's competition here
DocGo Inc. (NASDAQ: DCGO)
GRDN vs DCGO Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, DCGO has a market cap of 64.5M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while DCGO trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas DCGO's P/E ratio is -0.75. In terms of profitability, GRDN's ROE is +0.31%, compared to DCGO's ROE of -0.89%. Regarding short-term risk, GRDN is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check DCGO's competition here
AlerisLife Inc. (NASDAQ: ALR)
GRDN vs ALR Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas ALR's P/E ratio is -1.11. In terms of profitability, GRDN's ROE is +0.31%, compared to ALR's ROE of -0.15%. Regarding short-term risk, GRDN is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check ALR's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
GRDN vs PIII Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, PIII has a market cap of 35M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while PIII trades at $10.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas PIII's P/E ratio is -0.27. In terms of profitability, GRDN's ROE is +0.31%, compared to PIII's ROE of +1.61%. Regarding short-term risk, GRDN is less volatile compared to PIII. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check PIII's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
GRDN vs IMAC Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas IMAC's P/E ratio is -2.27. In terms of profitability, GRDN's ROE is +0.31%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, GRDN is more volatile compared to IMAC. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check IMAC's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
GRDN vs CCEL Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, CCEL has a market cap of 32.3M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while CCEL trades at $3.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas CCEL's P/E ratio is -13.33. In terms of profitability, GRDN's ROE is +0.31%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, GRDN is less volatile compared to CCEL. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check CCEL's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
GRDN vs EUDA Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, EUDA has a market cap of 26.4M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while EUDA trades at $14.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas EUDA's P/E ratio is -26.63. In terms of profitability, GRDN's ROE is +0.31%, compared to EUDA's ROE of +1.20%. Regarding short-term risk, GRDN is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check EUDA's competition here
Cano Health, Inc. (NYSE: CANO-WT)
GRDN vs CANO-WT Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, GRDN's ROE is +0.31%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, GRDN is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
GRDN vs AIH Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas AIH's P/E ratio is -2.78. In terms of profitability, GRDN's ROE is +0.31%, compared to AIH's ROE of +1.16%. Regarding short-term risk, GRDN is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check AIH's competition here
Cano Health, Inc. (NYSE: CANO)
GRDN vs CANO Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas CANO's P/E ratio is -0.01. In terms of profitability, GRDN's ROE is +0.31%, compared to CANO's ROE of -1.49%. Regarding short-term risk, GRDN is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
GRDN vs FPCG Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas FPCG's P/E ratio is 0.09. In terms of profitability, GRDN's ROE is +0.31%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, GRDN is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check FPCG's competition here
American Shared Hospital Services (AMEX: AMS)
GRDN vs AMS Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, AMS has a market cap of 9.9M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while AMS trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas AMS's P/E ratio is -6.74. In terms of profitability, GRDN's ROE is +0.31%, compared to AMS's ROE of -0.07%. Regarding short-term risk, GRDN is less volatile compared to AMS. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check AMS's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
GRDN vs FTRP Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas FTRP's P/E ratio is -1.22. In terms of profitability, GRDN's ROE is +0.31%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, GRDN is less volatile compared to FTRP. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check FTRP's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
GRDN vs BMGL Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, BMGL has a market cap of 8.6M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while BMGL trades at $5.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas BMGL's P/E ratio is -1.04. In terms of profitability, GRDN's ROE is +0.31%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, GRDN is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check BMGL's competition here
XWELL, Inc. (NASDAQ: XWEL)
GRDN vs XWEL Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, XWEL has a market cap of 7.9M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while XWEL trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas XWEL's P/E ratio is -0.18. In terms of profitability, GRDN's ROE is +0.31%, compared to XWEL's ROE of +2.89%. Regarding short-term risk, GRDN is less volatile compared to XWEL. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check XWEL's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
GRDN vs AIDX Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, AIDX has a market cap of 6.7M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while AIDX trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas AIDX's P/E ratio is -1.04. In terms of profitability, GRDN's ROE is +0.31%, compared to AIDX's ROE of +0.79%. Regarding short-term risk, GRDN is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check AIDX's competition here
ModivCare Inc. (NASDAQ: MODV)
GRDN vs MODV Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas MODV's P/E ratio is -0.06. In terms of profitability, GRDN's ROE is +0.31%, compared to MODV's ROE of +1.36%. Regarding short-term risk, GRDN is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
GRDN vs GBNH Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas GBNH's P/E ratio is -0.06. In terms of profitability, GRDN's ROE is +0.31%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, GRDN is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE)
GRDN vs RHE Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas RHE's P/E ratio is -1.79. In terms of profitability, GRDN's ROE is +0.31%, compared to RHE's ROE of -1.31%. Regarding short-term risk, GRDN is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check RHE's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
GRDN vs RHE-PA Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, GRDN's ROE is +0.31%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, GRDN is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check RHE-PA's competition here
Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst (NASDAQ: STLNW)
GRDN vs STLNW Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, STLNW has a market cap of 5M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while STLNW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas STLNW's P/E ratio is N/A. In terms of profitability, GRDN's ROE is +0.31%, compared to STLNW's ROE of N/A. Regarding short-term risk, GRDN is less volatile compared to STLNW. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check STLNW's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
GRDN vs TOIIW Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, GRDN's ROE is +0.31%, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, GRDN is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check TOIIW's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
GRDN vs IMACW Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas IMACW's P/E ratio is N/A. In terms of profitability, GRDN's ROE is +0.31%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, GRDN is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check IMACW's competition here
Nakamoto Inc. (NASDAQ: NAKAW)
GRDN vs NAKAW Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, NAKAW has a market cap of 1.5M. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while NAKAW trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas NAKAW's P/E ratio is -0.53. In terms of profitability, GRDN's ROE is +0.31%, compared to NAKAW's ROE of -1.05%. Regarding short-term risk, GRDN is more volatile compared to NAKAW. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check NAKAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
GRDN vs CCM Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, CCM has a market cap of 690.2K. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while CCM trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas CCM's P/E ratio is -0.32. In terms of profitability, GRDN's ROE is +0.31%, compared to CCM's ROE of +0.06%. Regarding short-term risk, GRDN is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
GRDN vs NIVF Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, NIVF has a market cap of 109.4K. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while NIVF trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas NIVF's P/E ratio is 0.28. In terms of profitability, GRDN's ROE is +0.31%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, GRDN is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check NIVF's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
GRDN vs MNDR Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, MNDR has a market cap of 42.3K. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while MNDR trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas MNDR's P/E ratio is -0.04. In terms of profitability, GRDN's ROE is +0.31%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, GRDN is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check MNDR's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
GRDN vs NIVFW Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, NIVFW has a market cap of 39.8K. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, GRDN's ROE is +0.31%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, GRDN is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check NIVFW's competition here
Talkspace, Inc. (NASDAQ: TALKW)
GRDN vs TALKW Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas TALKW's P/E ratio is 0.00. In terms of profitability, GRDN's ROE is +0.31%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, GRDN is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check TALKW's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
GRDN vs TLMD Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, TLMD has a market cap of 0. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas TLMD's P/E ratio is -1.60. In terms of profitability, GRDN's ROE is +0.31%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, GRDN is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check TLMD's competition here
New Frontier Health Corporation (NYSE: NFH)
GRDN vs NFH Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, NFH has a market cap of 0. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas NFH's P/E ratio is -19.75. In terms of profitability, GRDN's ROE is +0.31%, compared to NFH's ROE of -0.06%. Regarding short-term risk, GRDN is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check NFH's competition here
DocGo Inc. (NASDAQ: DCGOW)
GRDN vs DCGOW Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas DCGOW's P/E ratio is N/A. In terms of profitability, GRDN's ROE is +0.31%, compared to DCGOW's ROE of -0.89%. Regarding short-term risk, GRDN is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check DCGOW's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
GRDN vs DVCR Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, DVCR has a market cap of 0. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas DVCR's P/E ratio is 28.34. In terms of profitability, GRDN's ROE is +0.31%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, GRDN is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check DVCR's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
GRDN vs TVTY Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, TVTY has a market cap of 0. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas TVTY's P/E ratio is 19.06. In terms of profitability, GRDN's ROE is +0.31%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, GRDN is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check TVTY's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
GRDN vs TLMDW Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas TLMDW's P/E ratio is N/A. In terms of profitability, GRDN's ROE is +0.31%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, GRDN is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check TLMDW's competition here
Hanger, Inc. (NYSE: HNGR)
GRDN vs HNGR Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, HNGR has a market cap of 0. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas HNGR's P/E ratio is 19.71. In terms of profitability, GRDN's ROE is +0.31%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, GRDN is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check HNGR's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
GRDN vs ATIP-WT Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, GRDN's ROE is +0.31%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, GRDN is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check ATIP-WT's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
GRDN vs SLHGP Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, GRDN's ROE is +0.31%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, GRDN is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check SLHGP's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
GRDN vs SLHG Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, SLHG has a market cap of 0. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas SLHG's P/E ratio is -1.48. In terms of profitability, GRDN's ROE is +0.31%, compared to SLHG's ROE of N/A. Regarding short-term risk, GRDN is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check SLHG's competition here
Almost Family Inc. (NASDAQ: AFAM)
GRDN vs AFAM Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, AFAM has a market cap of 0. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas AFAM's P/E ratio is N/A. In terms of profitability, GRDN's ROE is +0.31%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, GRDN is less volatile compared to AFAM. This indicates lower risk in terms of short-term price fluctuations for GRDN.Check AFAM's competition here
Kindred Healthcare, Inc. (NYSE: KND)
GRDN vs KND Comparison August 2026
Guardian Pharmacy Services, Inc. (NYSE: GRDN) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRDN stands at 2.4B. In comparison, KND has a market cap of 0. Regarding current trading prices, GRDN is priced at $38.43 on the NYSE, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRDN currently has a P/E ratio of 33.72, whereas KND's P/E ratio is -1.14. In terms of profitability, GRDN's ROE is +0.31%, compared to KND's ROE of -0.53%. Regarding short-term risk, GRDN is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for GRDN.Check KND's competition here